Comparing Nyxoah (NASDAQ:NYXH) & P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ:PIII) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Earnings & Valuation

This table compares P3 Health Partners and Nyxoah”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.50 billion	0.03	-$135.85 million	($40.18)	-0.14
Nyxoah	$4.89 million	34.06	-$64.10 million	($2.49)	-1.96

Nyxoah has lower revenue, but higher earnings than P3 Health Partners. Nyxoah is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

P3 Health Partners has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for P3 Health Partners and Nyxoah, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1	0	1	0	2.00
Nyxoah	1	0	3	0	2.50

P3 Health Partners currently has a consensus price target of $12.50, indicating a potential upside of 129.15%. Nyxoah has a consensus price target of $12.67, indicating a potential upside of 159.03%. Given Nyxoah’s stronger consensus rating and higher possible upside, analysts clearly believe Nyxoah is more favorable than P3 Health Partners.

Insider and Institutional Ownership

7.8% of P3 Health Partners shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares P3 Health Partners and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-9.07%	-302.33%	-16.72%
Nyxoah	-1,457.97%	-101.99%	-66.74%

Summary

Nyxoah beats P3 Health Partners on 8 of the 14 factors compared between the two stocks.

About P3 Health Partners

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.